IDEXX Laboratories Inc (IDXX)

NASDAQHealthcare

$569.41
+$4.75 (+0.8%)
Market closed

April 2, 2026 at 20:00 UTC

Interactive Chart

IDXX
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

07:17:07 UTC

About IDEXX Laboratories Inc

Name
IDEXX Laboratories Inc
CEO
Jonathan J. Mazelsky
Industry
Healthcare
Year Founded
1983
Employees
11,000

IDEXX Laboratories Inc is a veterinary diagnostics and software company that helps animal health providers turn samples and records into practical decisions. Clinics rely on in-clinic instruments, reference lab services, and connected practice tools that present results in clear context rather than scattered reports. The operating idea is straightforward: make testing easy to run, make data easy to read, and keep workflows familiar so teams can move from intake to treatment without losing time. In water quality and livestock testing, the same discipline applies — methods that are auditable and results that travel well between sites. Regional units adapt to local regulation while holding to shared quality systems and data safeguards. Within the healthcare ecosystem, IDEXX occupies the quiet infrastructure of veterinary care, supporting better medicine through repeatable processes that work on busy days as well as calm ones.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 1 Buy, 7 Hold, 15 Sell
Buy1
Hold7
Sell15

Fundamentals & Financials

Revenue (TTM)
$4.3B
Net Income (TTM)
$1B
EPS (TTM)
$13.17
ROA (TTM)
31.62%
Current Ratio
1.17
Dividend Yield
-

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue$1,090.5M
Cost of Sales$432,465K
Gross Profit$658,114K
Operating Income$315,605K
Net Income$248,188K
EPS$3.1

Technical Indicators

IDEXX Laboratories Inc's Technical Indicators Summary

IDXX shows a bearish technical picture with clear downside momentum: RSI is low, MACD is negative and short-term momentum readings point lower, while ADX signals a reasonably strong trending environment. The stock trades well below its key medium- and long-term moving averages, including the 200-day, which underlines the prevailing negative bias. Volatility is muted relative to the move and on-balance volume is negative, suggesting distribution rather than accumulation. The pivot near 560 is a nearby reference point. Technical takeaway: Bearish — downhill momentum and chart structure favor sellers.

Buy
1 signal
Neutral
7 signals
Sell
15 signals
Overall: Bearish65% Bearish signals
IndicatorValue
RSI (14)
33.08
Stochastic %K (14, 3, 3)
10.23
CCI (20)
-112.46
WPR (14)
-74.00
Momentum (10)
-25.09
MFI
37.11
MACD Level (12, 26)
-19.67
Bollinger Bands
$540.24 - $631.11
ATR (14)
$17.14 (3.05%)
ADX (14)
32.54
OBV
8,517,486
Classic Pivot Point
$560.18
Fibonacci Pivot Point
$560.18
Simple Moving Averages
$570.93 - $666.98(5 indicators)
Exponential Moving Averages
$571.17 - $634.40(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The session ended with IDXX modestly above yesterday, holding a 0.87% gain and closing near 569.55. End-of-day options data show heavy put demand in IDXX, leaving the put/call ratio at 1.74. IDXX ends the session modestly higher as heavy put demand signals hedging into the move.

Price Change

from $569.42 close

+$0.09

Trading Volume

Above avg 534.9K

693.7K

vs S&P 500 Today

Strong Outperformance

+4.78%

52-Week Position

Mid-range

51.6%

Updated: April 3, 2026 at 20:09 UTC

Quote Summary

OpenPrevious Close
$560.04$565.48
Day Range52 Week Range
$548.51 - $566.57$356.14 - $769.98
VolumeAvg. Volume
813.4K511.2K
Market CapP/E Ratio
$44.8B42.9